Alector, Inc. (ALEC) stock analysis
In our weekly check, Alector, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 3, red flags: 9.
About Alector, Inc.
Alector, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ALEC.
What our checks show for ALEC
Red flags
- Operating cash flow is negative while the company reports a profit: the profit does not arrive as cash.
- Weak EPS forecast
- Analysts expect revenue to shrink about 73.1% a year.
- Analysts expect the net margin to shrink by 789 points from today's 23.9%.
- Free cash flow is negative (-106% of revenue): the business spends more cash than it brings in.
- The price swings a lot: 80.8% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 98% from a peak. Would you have held through that?
- The share count grew by 23% in 2 years: each shareholder owns a smaller slice.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- Earnings per share fell 40% a year over the last 3 years.
- A small company (market value $378 million): usually riskier and followed by fewer analysts.
- The stock is still below its previous peak.
Strengths
- Debt is low: 0.18x equity.
- The net margin rose by 41.4 points over 5 years, to 23.9%.
- The gross margin is 100% and has risen by 91.5 points: pricing power is holding.
- The company keeps 23.9% of its revenue as net profit.
- The price is 7.3 times earnings (P/E), reasonable for its growth.
- Beta 0.61: the stock usually moves less than the market.
Similar companies
NGNE · SPRY · CRMD · RZLT · LYEL · FENC
Questions
What grade does Alector, Inc. (ALEC) have?
In our weekly check, Alector, Inc. is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 3, red flags: 9. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ALEC stock?
This week's biggest flags for Alector, Inc.: Profits not backed by cash, Weak EPS forecast, Weak revenue forecast. In total 12 of 22 checks show a warning or a red flag.
What does Alector, Inc. do?
Alector, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ALEC.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis